Document is current
Any future updates will be listed below
-
Authors
Park, Hong-Kyun https://orcid.org/0000-0002-8120-2469
Kim, Jun Yup
Hong, Keun-Sik
Cho, Yong-Jin
Park, Jong-Moo
Lee, Dongwhane
Kang, Kyusik
Lee, Soo Joo
Kim, Jae Guk
Cha, Jae-Kwan
Kim, Dae-Hyun
Han, Moon-Ku
Kim, Beom Joon
Kang, Jihoon
Park, Tai Hwan
Park, Sang-Soon
Choi, Jin Kyo
Lee, Kyungbok
Lee, Jeong-Yoon
Lee, Jun
Kwon, Doo Hyuk
Lee, Byung-Chul
Yu, Kyung-Ho
Oh, Mi Sun
Lee, Minwoo
Park, Man-Seok
Kim, Joon-Tae
Choi, Kang-Ho
Kim, Hyunsoo
Kim, Dong-Eog
Gwak, Dong-Seok
Choi, Jay Chol
Kim, Joong-Goo
Kang, Chul-Hoo
Kwon, Jee-Hyun
Kim, Wook-Joo
Shin, Dong-Ick
Yum, Kyu Sun
Sohn, Sung Il
Hong, Jeong-Ho
Park, Hyungjong
Kim, Chulho
Lee, Sang-Hwa
Park, Kwang-Yeol
Jeong, Hae-Bong
Park, Chan-Young
Oh, Kyungmi
Kim, Chi Kyung
Han, Jung Hoon
Lee, Keon-Joo
Heo, Sung Hyuk
Woo, Ho Geol
Lee, Juneyoung
Bae, Hee-Joon
-
Funding
Funding for this research was provided by:
Dong-A ST Pharm
Korea National Institute of Health research project (2023-ER-1006-01)
- License Information
-
More Information
Article History
Received: 22 January 2025
Accepted: 22 August 2025
First Online: 26 September 2025
Declarations
:
: The study protocol was reviewed and approved by the Institutional Review Boards of all participating centers (B-2109–707-002). Written informed consent will be obtained by each site investigator from all eligible participants prior to randomization.
: Not applicable.
: The author(s) declare the following potential conflicts of interest regarding the research, authorship, and/or publication of this article: BN has received personal honoraria for serving on the Data and Safety Monitoring Board (DSMB) for the THALES trial (sponsored by AstraZeneca). H-JB has received grants from Bayer Korea, Bristol Myers Squibb Korea, Chong Gun Dang Pharmaceutical Corp., Dong-A ST, Korean Drug Co., Ltd., Samjin Pharm, and Takeda Pharmaceuticals Korea Co., Ltd. In addition, H-JB has received personal fees from Amgen Korea, Bayer, Daiichi Sankyo, JW Pharmaceutical, Hanmi Pharmaceutical Co., Ltd., Otsuka Korea, SK chemicals, and Viatris Korea outside the scope of the submitted work.
